Form 4: Dayforce Executive Stephen Holdridge Sells 1,000 Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Stephen Holdridge, President of Customer & Revenue Operations at Dayforce, Inc., sold 1,000 shares of common stock at $55.01 per share on August 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On August 15, 2024, Stephen Holdridge, President of Customer & Revenue Operations at Dayforce, Inc., sold 1,000 shares of the company's common stock.
- The sale was executed at a price of $55.01 per share.
- The transaction was conducted under a Rule 10b5-1 trading plan adopted by Holdridge on May 7, 2024.
- Following the transaction, Holdridge directly owns 103,437 shares of Dayforce common stock.
- This total includes shares acquired through the company's Global Employee Stock Purchase Plan (GESPP) and shares issuable pursuant to restricted stock units (RSUs).
- Holdridge also holds options to buy 65,547 shares at an exercise price of $70.73, which are fully vested and exercisable.
- Additionally, Holdridge holds various performance units (PSUs) that represent a contingent right to receive shares of common stock based on the achievement of certain performance metrics.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of an insider stock sale. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Future Outlook
The document does not contain specific forward-looking statements, but it does detail the vesting schedules for RSUs and the potential conversion of PSUs based on future performance.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. It provides transparency into the transactions of company executives and their holdings of company stock.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives.
- The use of 10b5-1 trading plans is a common method for insiders to sell shares without being accused of trading on non-public information, similar to practices at companies like Salesforce and Workday.
- The vesting schedules and performance-based equity awards are typical components of executive compensation packages, aligning with industry norms seen at companies like Oracle and SAP.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some investors, but the use of a 10b5-1 plan mitigates concerns about insider trading.
- The vesting schedules for RSUs and PSUs impact the executive's compensation and alignment with company performance.
Key Dates
| Date | Description |
|---|---|
| May 7, 2024 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| August 15, 2024 | Date of the transaction (sale of common stock) |
| August 19, 2024 | Date of the signature on the form |
| February 24, 2025 | Vesting date for 7,059 shares of Common Stock issuable pursuant to restricted stock unit (RSU) |
| February 28, 2025 | Vesting date for 9,141 shares of Common Stock issuable pursuant to RSUs |
| March 1, 2025 | Vesting date for 12,210 shares of Common Stock issuable pursuant to RSUs |
| February 28, 2026 | Vesting date for 9,141 shares of Common Stock issuable pursuant to RSUs |
| March 1, 2026 | Vesting date for 12,210 shares of Common Stock issuable pursuant to RSUs |
| March 1, 2027 | Vesting date for 12,210 shares of Common Stock issuable pursuant to RSUs |
| February 28, 2030 | Expiration date for Option (right to buy) |
| February 28, 2033 | Expiration date for Performance Units |
| February 24, 2032 | Expiration date for Performance Units |
| March 1, 2034 | Expiration date for Performance Units |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.